ARCHIVES

Response From Center Representatives In L.A. To NCI Questions Is “Frusterating,” DeVita Says

This article is from The Cancer Letter archive.

Vol. 10 No. 15 | April 13, 1984

Download PDF Visit The Full Archive

Related Articles

FDA Approves Evista for Breast Cancer Risk Reduction.

September 14, 2007

Study Finds No Benefit From CT In Lung Cancer; Advocacy Group Alleges “Delaying Tactic.”

March 9, 2007

NCI Advisory Group, Other Cancer Meetings

February 22, 1985

Studies Are Demonstrating Effectiveness Of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 12, 1974

Momentum Continues For Private Development Of Free Standing Cancer Centers

July 19, 1985

In Brief: Pitot Appointed To Cancer Panel, Replacing Jako; Fisher, Wattenberg, Curtiss Lead Cancer Groups

May 29, 1992